英文名稱(chēng) | Ophiopogonin D |
---|---|
中文名稱(chēng) | 麥冬皂苷D |
CAS號(hào) | 41753-55-3 |
分子式 | C44H70O16 |
分子量 | 855.02 |
外觀(guān) | 白色粉末 |
熔點(diǎn) | 263-265 °C |
沸點(diǎn) | - |
酸度系數(shù)pKa | 13.01±0.70 | Condition: Most Acidic Temp: 25 °C |
英文名稱(chēng) | Ophiopogonin D |
---|---|
中文名稱(chēng) | 麥冬皂苷D |
CAS號(hào) | 41753-55-3 |
分子式 | C44H70O16 |
分子量 | 855.02 |
外觀(guān) | 白色粉末 |
熔點(diǎn) | 263-265 °C |
沸點(diǎn) | - |
酸度系數(shù)pKa | 13.01±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000370
中文名稱(chēng):麥冬皂苷D
英文名稱(chēng):Ophiopogonin D
英文別名:(1β,3β,25 R )-3-Hydroxyspirost-5-en-1-yl O -6-deoxy-α-L-mannopyranosyl-(1→2)- O -[β-D-xylopyranosyl-(1→3)]-6-deoxy-β-D-
galactopyranoside; 25( R )-Ruscogenin 1- O -[α-L-rhamnopyranosyl-(1→2)][β-D-xylopyranosyl-(1→3)]-β-D-fucopyranoside; Deacetylophiopogonin C;
OJV-V; Ophiopogonin D
分子式:C44H70O16
分子量:855.02
CAS號(hào):41753-55-3
純度:HPLC≥98%
熔點(diǎn):263-265 °C
密度:1.40±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)13.01±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件:-20℃,干燥、避光、密封
規(guī)格:5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶(hù)需求包裝
供應(yīng)單位:四川省維克奇生物科技有限公司
供應(yīng)電話(huà):028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類(lèi)標(biāo)準(zhǔn)品和天然植物有效單體,主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體,化學(xué)合成,抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲(chóng)草系列等,敬請(qǐng)關(guān)注! 新批次有現(xiàn)貨,歡迎咨詢(xún)。
Ophiopogonin D, a Steroidal Glycoside Abrogates STAT3 Signaling Cascade and Exhibits Anti-Cancer Activity by Causing GSH/GSSG Imbalance in Lung Carcinoma | ||
來(lái)源:SCI:Cancers | 作者:Jong Hyun Lee | 備注:影響因子:5.326 |
引用描述 | ||
Ophiopogonin D (OP-D, Figure 1A) was purchased from Sichuan Weikeqi Biological Technology Co. Ltd. (Chengdu, China). Stock solution of OP-D (100 mM) was prepared using dimethyl sulfoxide, stored at ?80 °C, and diluted in cell culture medium for use. LightShift? Chemiluminescent EMSA kit |
Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction | ||
來(lái)源:SCI:PHARMACOLOGICAL RESEARCH | 作者:Min Xu | 備注:影響因子:4.816 |
引用描述 | ||
hecogenin (1), diosgenin (2), ruscogenin (3), gitogenin (4), tigogenin (5), solasodine (6), (24S,25S)-3β, 24-di-hydroxy-5α-spirostan (7), dracaenol C (8), 25(27)-dehydroruscogenin (9), (1β, 3β, 14α, 15α, 20R, 22S, 25R)-spirost-5-ene-tetrol (10), peimine (11), peiminine (12), peimisine (13), isoverticine (14), trillin (15), polyphyllin VI (16), polyphyllin VII (17), pallidifloside D (18), prosapogenin A (19), spongipregnoloside A (20), dioscin(21), solasonine (22), solamargine (23), gracillin (24), polyphyllin I(25), timosaponin BII (26), timosaponinA-III(27), ophiopogonin D (28), protobioside (29), (22S,25S)-26-O-β-d-glucopyranosyl-22,25-epoxyfurost-5-en-3β,26-diol-3-O-α-l-rha-mnopyranosyl(1 → 2)-β-d-gluc (30), pallidifloside E (31), parispseudoside (32), methylprotodioscin (33), protodioscin (34), pseudoprotodioscin (35), YS-IX (36), pallidifloside A (37), pallidifloside H (38), digoxin (39), bisdigoxigenin (40), 7β, 14α, 21-tri-hydroxy-diosgenin (41), 12β,14α,21-tri-hydroxy-diosgenin (42), and 11β,14α-di-hydroxyldiosgenin (43) were purchase from Sichuan weikeqi biotechnology company (Sichuan province, China). Pooled human liver microsomes (HLMs, 20 mg/mL) and pooled human primary hepatocytes were purchased from Rild Research Institute for LiverDiseases (Shanghai, China). |
Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells | ||
來(lái)源:SCI:PHYTOMEDICINE | 作者:Jong Hyun Lee | 備注:影響因子:3.61 |
引用描述 | ||
Ophiopogonin D (OP-D, Fig. 1A) was purchased from Sichuan Weikeqi Biological Technology Co., Ltd (Sichuan, China). Dimethyl sulfoxide was used to prepare an OP-D stock solution (100?mM), which was then kept at ?80 °C and diluted in a cell culture medium. Antibodies against IκB-α, p-IκB-α, p65, p-p65(ser276), AKT, c-Fos, c-Jun, Bcl-xL, IAP2, MMP-9, Caspase-3, PARP, Survivin, β-actin, and Lamin B, goat anti-mouse IgG-HRP |
The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase | ||
來(lái)源:SCI:Evidence-based Complementary and Alternative Medicine | 作者:Jiang Li-Peng | 備注:影響因子:2.175 |
引用描述 | ||
UGT1A10, UGT2B4, UGT2B7, and UGT2B15) expressed in baculovirus-infected insect cells were obtained from BD Gentest Corp. (Woburn, MA, USA). Ophiopogonin D (OD), ophiopogonin D′ (OD′), methylophiopogonanone A (MA), methylophiopogonanone B (MB), and ruscorectal (RU) were purchased from Sichuan Weikeqi Biotechnology Company (Chengdu, Sichuan, China). The purity of these compounds was above 95%. All other reagents were of HPLC grade or of the highest grade commercially available. |
Ophiopogonin D of <i>Ophiopogon japonicus</i> ameliorates renal function by suppressing oxidative stress and inflammatory response in streptozotocin-induced diabetic nephropathy rats | ||
來(lái)源:SCI:BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH | 作者:Qiao Yanhong | 備注:影響因子:2.023 |
引用描述 | ||
OP-D (purity ≥98%, HLPC) was obtained from Sichuan Weikeqi Biological Techology Co. (China). STZ was obtained from Sigma-Aldrich (USA) and gliclazide (Glic, 99.2%) was obtained from the Servier (Tianjin) Pharmaceutical Co. (China). |